South Sudan vs Togo: Population requiring preventive chemotherapy for schistosomiasis
South Sudan
3.75 million
in 2024
Togo
3.19 million
in 2024
South Sudan rank
22nd
Togo rank
25th
Population requiring preventive chemotherapy for schistosomiasis over time
- South Sudan
- Togo
How they compare
South Sudan currently reports 3.75 million against 3.19 million in Togo, a difference of 559,150.
That makes South Sudan's figure about 1.2 times Togo's.
The two have swapped places 4 times across 12 shared years of data; in 2013 it was South Sudan ahead.
South Sudan ranks 22nd and Togo ranks 25th of 52 countries.
Across the 2 decades both report, South Sudan averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | South Sudan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.57 million | 3.10 million | 531,040 | Togo |
| 2020s | 3.48 million | 3.39 million | 84,572 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, South Sudan or Togo?
- South Sudan, at 3.75 million against 3.19 million in Togo as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between South Sudan and Togo?
- 559,150, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Togo?
- 12 years are reported by both, from 2013 to 2024.
- How do South Sudan and Togo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- South Sudan ranks 22nd and Togo ranks 25th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.